The Science of When and How Much
Every post in this series has touched, implicitly or explicitly, on pharmacokinetics: the absorption timelines that make edibles different from smoking, the half-lives that drive the testing absurdities of the workplace post, the onset windows that the redose traps exploit and the overdose windows that the response-times close. Pharmacokinetics (what the body does to the drug: absorption, distribution, metabolism, excretion, and the timing of each) and its sibling pharmacodynamics (what the drug does to the body) are the twin sciences beneath every dosing decision, every interaction warning, and every harm reduction rule this series has offered, and they deserve the explicit primer this post provides: the concepts, the vocabulary, and the practical rules of timing that the series' readers can apply to every substance conversation, including the ones the series has not covered.
The Core Concepts
Absorption is the journey from administration to bloodstream, and its route determines its speed. Inhalation (lungs, enormous surface area, direct arterial access) delivers in seconds to minutes: the fastest route, which is why smoking and vaping dominate the acute-use patterns and why the rapid-onset drugs carry the compulsive-reinforcement profiles this series has documented. Oral absorption (the stomach and intestine, then the liver's first-pass metabolism) delivers in minutes to hours, slower and less predictable: the edible timeline of this series' edibles post (thirty minutes to two hours, the delayed peak, the redose trap) is the oral-route pharmacokinetics in action, and the first-pass effect (the liver metabolizing a fraction of the dose before it reaches the systemic circulation, converting THC to the more potent 11-hydroxy-THC) is the chemistry behind the edible experience's distinct character. Sublingual and buccal absorption (under the tongue, through the oral mucosa's rich vasculature, bypassing first-pass) splits the difference: faster than oral, slower than inhalation, the delivery logic of the sublingual tinctures and the oral tobacco products. Transdermal (through the skin, slow and steady, the patches) and injection (instant and complete, the highest-risk route) round out the absorption routes, each with its own timing and its own risk signature.
Distribution is the drug's travel from the bloodstream to its sites of action, and its key variable is the blood-brain barrier and the lipid-solubility that determines crossing: the THC's lipophilicity (fat-loving, crossing fast, depositing in fat tissue and leaching back slowly, the pharmacokinetic basis of the long detection window the workplace-testing post documented) versus the water-soluble molecules' different profiles. Distribution also determines the onset of the tissue effects (the minutes that alcohol's water-solubility and the brain's blood-flow make nearly immediate) and the compartment dynamics that complicate the chronic-use pictures (the fat-stored cannabinoids, the tissue reservoirs that the tolerance and withdrawal posts touched).
Metabolism is the liver's processing (the CYP450 enzymes of this series' interaction post doing the work, converting the active drug to metabolites that may be active, inactive, or toxic) and its half-life is the master timing variable: the time for the body's drug concentration to fall by half, determining the duration of effect, the dosing interval, the withdrawal timing, and the detection window. The half-life distributions explain the series' timing patterns everywhere: ethanol's short half-life (the hours-long arc, the next-morning impairment question), THC's long and variable one (the days-to-weeks of the chronic user's detection), the benzodiazepines' spectrum (the short-acting Xanax's rapid offset and rebound-anxiety potential versus the long-acting Valium's accumulation and its use in the tapering protocols), and the fentanyl's pharmacokinetic trickiness (the lipophilicity and the tissue release that sustain the effect past the blood-level decline, the reversal-duration challenge of the naloxone posts).
Excretion completes the picture (the kidneys and the bile clearing the metabolites, the urinary-detection windows that the testing regime measures), and the elimination kinetics determine the last practical timing variable: how long after the last dose the effects, the impairment, and the detectability persist.
The Practical Rules of Timing
The pharmacokinetic literacy, compressed into the rules the series' readers can apply everywhere:
Route determines speed, and speed determines risk. The faster the onset, the stronger the reinforcement (the series' cocaine and smoking coverage) and the harder the titration (the user's ability to stop at the right dose exists only when the feedback is immediate, which the oral-route delay of the edibles post removes, producing the redose trap).
Half-life determines the schedule. The dosing interval that the half-life sets (the coffee's morning dosing, the medication schedules, the binge patterns that the short-half-life stimulants drive) and the withdrawal timing that the elimination sets (the onset windows this series' withdrawal posts documented, from alcohol's morning shakes to the benzodiazepines' delayed dangerous windows).
First-pass determines the character. The oral route's liver conversion changes the drug (THC to 11-hydroxy-THC, morphine's oral-to-injectable potency differences, the prodrugs like codeine that only become active through metabolism), which is why the same molecule at the same nominal dose can produce different experiences by different routes.
The detection window is not the impairment window. The urinalysis measures excretion (the metabolites' half-lives), not function (the parent drug's active presence), and the workplace post's absurdities (the Friday-night joint failing Monday's test, the weekend cocaine passing it) are the pharmacokinetic decoupling made policy.
The interaction timing is pharmacokinetic. The CYP450 inhibition and induction (the grapefruit juice, the CBD, the enzyme-inducing medications) change the metabolism, not the drug, and the interaction windows follow the enzyme dynamics (the days of the inhibition's persistence, the weeks of the induction's onset) rather than the drugs' own half-lives.
The Series' Timing Atlas
The closing section assembles the series' timing atlas in one table, the practical reference this post exists to provide: the onset times (seconds for the smoked and injected, minutes for the sublingual and insufflated, thirty-to-one-hundred-twenty minutes for the oral), the peak windows (the edibles' two-to-four-hour delay, the cocaine's minutes-to-hour, the LSD's two-to-three-hour come-up), the duration arcs (the cannabis-smoke's three-to-four hours against the edible's six-to-eight, the psilocybin's four-to-six against the LSD's ten-to-twelve, the nitrous's minutes against the methamphetamine's eight-to-twelve), the half-life implications (the buprenorphine's long arc enabling the alternate-day dosing, the fentanyl's tissue-release complicating the naloxone windows), and the detection windows (the urinalysis timelines of the workplace post, the blood-THC impairment correlations of the driving post). The atlas is the series' harm reduction rules in their native language, and the reader who learns to read it can derive the rules for any drug the series has not covered from the pharmacokinetic facts alone.
The Bottom Line
Pharmacokinetics is the science of the when (absorption's speed, the half-life's schedule, the peak's timing, the excretion's persistence), and every harm reduction rule this series has offered is a pharmacokinetic rule wearing practical clothing: the edible's redose trap is first-pass metabolism and delayed absorption, the redose compulsion is rapid onset and short half-life, the testing absurdities are excretion windows decoupled from impairment, the interaction warnings are enzyme dynamics, and the withdrawal timings are elimination schedules. The series' readers who internalize the timing atlas hold the toolkit in its native form, portable to every new substance, every new product, and every new market the chemistry invents next, which is the deepest education this series can offer: not the rules for the drugs of today, but the science from which the rules derive, ready for the molecules of tomorrow.
